|
1
|
World Health Organization (WHO), .
International Agency for Research on Cancer. WHO; Geneva: 2020
|
|
2
|
Pickhardt PJ, Lonergan GJ, Davis CJ Jr,
Kashitani N and Wagner BJ: From the archives of the AFIP.
Infiltrative renal lesions: Radiologic-pathologic correlation.
Armed forces institute of pathology. Radiographics. 20:215–243.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Minervini A, Carini M, Uzzo RG, Campi R,
Smaldone MC and Kutikov A: Standardized reporting of resection
technique during nephron-sparing surgery: The
surface-intermediate-base margin score. Eur Urol. 66:803–805. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang L, Feng J, Alvarez H, Snarskis C,
Gupta G and Picken MM: Critical histologic appraisal of the
pseudocapsule of small renal tumors. Virchows Arch. 467:311–317.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Minervini A, di Cristofano C, Lapini A,
Marchi M, Lanzi F, Giubilei G, Tosi N, Tuccio A, Mancini M, della
Rocca C, et al: Histopathologic analysis of peritumoral
pseudocapsule and surgical margin status after tumor enucleation
for renal cell carcinoma. Eur Urol. 55:1410–1418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Azhar RA, de Castro Abreu AL, Broxham E,
Sherrod A, Ma Y, Cai J, Gill TS, Desai M and Gill IS: Histological
analysis of the kidney tumor-parenchyma interface. J Urol.
193:415–422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho S, Lee JH, Jeon SH, Park J, Lee SH,
Kim CH, Sung JY, Kim JH, Pyun JH, Lee JG, et al: A prospective,
multicenter analysis of pseudocapsule characteristics: Do all
stages of renal cell carcinoma have complete pseudocapsules? Urol
Oncol. 35:370–378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kryvenko ON: Characteristics of the
peritumoral pseudocapsule vary predictably with histologic subtype
of T1 renal neoplasms. Jacob JM, Williamson SR, Gondim DD, Leese
JA, Terry C, Grignon DJ, Boris RS.Urology. November
2015;86(5):956-961. Urol Oncol. 35:453–454. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mantoan Padilha M, Billis A, Allende D,
Zhou M and Magi-Galluzzi C: Metanephric adenoma and solid variant
of papillary renal cell carcinoma: Common and distinctive features.
Histopathology. 62:941–953. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kryvenko ON, Haley SL, Smith SC, Shen SS,
Paluru S, Gupta NS, Jorda M, Epstein JI, Amin MB and Truong LD:
Haemangiomas in kidneys with end-stage renal disease: A novel
clinicopathological association. Histopathology. 65:309–318. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cho HJ, Kim SJ, Ha US, Hong SH, Kim JC,
Choi YJ and Hwang TK: Prognostic value of capsular invasion for
localized clear-cell renal cell carcinoma. Eur Urol. 56:1006–1012.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Snarskis C, Calaway AC, Wang L, Gondim D,
Hughes I, Idrees MT, Kliethermes S, Maniar V, Picken MM, Boris RS
and Gupta GN: Standardized reporting of microscopic renal tumor
margins: introduction of the renal tumor capsule invasion scoring
system. J Urol. 197:23–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brierley J, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumours. Eigth edition. Wiley
Blackwell/John Wiley & Sons, Inc; Chichester, UK: pp. 199–201.
2017
|
|
14
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toyokuni S, Uchida K, Okamoto K,
Hattori-Nakakuki Y, Hiai H and Stadtman ER: Formation of
4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules
of rats treated with a renal carcinogen, ferric nitrilotriacetate.
Proc Natl Acad Sci USA. 91:2616–2620. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vargas-Olvera CY, Sánchez-González DJ,
Solano JD, Aguilar-Alonso FA, Montalvo-Muñoz F, Martínez-Martínez
CM, Medina-Campos ON and Ibarra-Rubio ME: Characterization of
N-diethylnitrosamine-initiated and ferric
nitrilotriacetate-promoted renal cell carcinoma experimental model
and effect of a tamarind seed extract against acute nephrotoxicity
and carcinogenesis. Mol Cell Biochem. 369:105–117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
National Research Council, . Guide for the
care and use of laboratory animals: Eighth edition. The National
Academies Press; Washington, DC, USA: pp. 11–18. 2011
|
|
18
|
Miyake M, Tanaka N, Hori S, Ohnishi S,
Takahashi H, Fujii T, Owari T, Ohnishi K, Iida K, Morizawa Y, et
al: Dual benefit of supplementary oral 5-aminolevulinic acid to
pelvic radiotherapy in a syngenic prostate cancer model. Prostate.
79:340–351. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vandesompele J, De Preter K, Pattyn F,
Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate
normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol.
3:research0034.0031. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
22
|
Butcher DT, Alliston T and Weaver VM: A
tense situation: Forcing tumour progression. Nat Rev Cancer.
9:108–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Handorf AM, Zhou Y, Halanski MA and Li WJ:
Tissue stiffness dictates development, homeostasis, and disease
progression. Organogenesis. 11:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujimoto N, Sugita A, Terasawa Y and Kato
M: Observations on the growth rate of renal cell carcinoma. Int J
Urol. 2:71–76. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oda T, Miyao N, Takahashi A, Yanase M,
Masumori N, Itoh N, Tamakawa M and Tsukamoto T: Growth rates of
primary and metastatic lesions of renal cell carcinoma. Int J Urol.
8:473–477. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lohi J, Korhonen M, Leivo I, Kangas L,
Tani T, Kalluri R, Miner JH, Lehto VP and Virtanen I: Expression of
type IV collagen alpha1(IV)-alpha6(IV) polypeptides in normal and
developing human kidney and in renal cell carcinomas and
oncocytomas. Int J Cancer. 72:43–49. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Best SL, Liu Y, Keikhosravi A, Drifka CR,
Woo KM, Mehta GS, Altwegg M, Thimm TN, Houlihan M, Bredfeldt JS, et
al: Collagen organization of renal cell carcinoma differs between
low and high grade tumors. BMC Cancer. 19:4902019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Provenzano PP, Eliceiri KW, Campbell JM,
Inman DR, White JG and Keely PJ: Collagen reorganization at the
tumor-stromal interface facilitates local invasion. BMC Med.
4:382006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y and
Chen KN: Matrix metalloproteinases expression correlates with
survival in patients with esophageal squamous cell carcinoma. Am J
Gastroenterol. 100:1835–1843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyata Y, Iwata T, Ohba K, Kanda S,
Nishikido M and Kanetake H: Expression of matrix
metalloproteinase-7 on cancer cells and tissue endothelial cells in
renal cell carcinoma: Prognostic implications and clinical
significance for invasion and metastasis. Clin Cancer Res.
12:6998–7003. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ogawa M, Ikeuchi K, Watanabe M, Etoh K,
Kobayashi T, Takao Y, Anazawa S and Yamazaki Y: Expression of
matrix metalloproteinase 7, laminin and type IV collagen-associated
liver metastasis in human colorectal cancer: Immunohistochemical
approach. Hepatogastroenterology. 52:875–880. 2005.PubMed/NCBI
|
|
32
|
Liao HY, Da CM, Liao B and Zhang HH: Roles
of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem.
92:9–18. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ishikawa T, Kimura Y, Hirano H and Higashi
S: Matrix metalloproteinase-7 induces homotypic tumor cell
aggregation via proteolytic cleavage of the membrane-bound
Kunitz-type inhibitor HAI-1. J Biol Chem. 292:20769–20784. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Motzer RJ, Banchereau R, Hamidi H, Powles
T, McDermott D, Atkins MB, Escudier B, Liu LF, Leng N, Abbas AR, et
al: Molecular subsets in renal cancer determine outcome to
checkpoint and angiogenesis blockade. Cancer Cell. 38:803–817.e4.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohe C, Yoshida T, Amin MB, Atsumi N, Ikeda
J, Saiga K, Noda Y, Yasukochi Y, Ohashi R, Ohsugi H, et al:
Development and validation of a vascularity-based architectural
classification for clear cell renal cell carcinoma: correlation
with conventional pathological prognostic factors, gene expression
patterns, and clinical outcomes. Mod Pathol. 35:816–824. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cioca A, Muntean D and Bungardean C: CD105
as a tool for assessing microvessel density in renal cell
carcinoma. Indian J Pathol Microbiol. 62:239–243. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rooney MS, Shukla SA, Wu CJ, Getz G and
Hacohen N: Molecular and genetic properties of tumors associated
with local immune cytolytic activity. Cell. 160:48–61. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M,
Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A,
et al: Tumor immune microenvironment characterization in clear cell
renal cell carcinoma identifies prognostic and
immunotherapeutically relevant messenger RNA signatures. Genome
Biol. 17:2312016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Galon J, Pagès F, Marincola FM, Angell HK,
Thurin M, Lugli A, Zlobec I, Berger A, Bifulco C, Botti G, et al:
Cancer classification using the immunoscore: A worldwide task
force. J Transl Med. 10:2052012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pagès F, Mlecnik B, Marliot F, Bindea G,
Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, et al:
International validation of the consensus immunoscore for the
classification of colon cancer: A prognostic and accuracy study.
Lancet. 391:2128–2139. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fridman WH, Zitvogel L, Sautès-Fridman C
and Kroemer G: The immune contexture in cancer prognosis and
treatment. Nat Rev Clin Oncol. 14:717–734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Edgar R, Domrachev M and Lash AE: Gene
expression omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
